Global Urology Market

Urology Comprehensive Study by Therapies (Medications, Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)}, Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others}), End Users (Hospitals & Clinics, Ambulatory Surgical Centers, Dialysis Centers, Nephrological Centers), Disease Type (Benign prostatic hyperplasia, Cancer, Urinary Tract Infection, Stone Diseases, Others), Gender (Male, Female) Players and Region - Global Market Outlook to 2030

Urology Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Urology Market Scope
Urology, also known as genitourinary surgery is a branch of medicine that focuses on the medical conditions of urinary systems diseases. Increasing urinary conditions including kidney stone and prostate problems in people due to changes in lifestyle and inadequate physical exercise have created noteworthy growth for the market. Further, more and more urologists are shifting towards the adoption of cutting-edge medical devices to treat patients with low invasion and perform surgical processes rapidly. In the surgical process, robotic surgeries are gaining much popularity and are extensively applied for the treatment of prostate cancer as it allows access to anatomical areas that are difficult to reach in non-robotic surgeries.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledAdvanced MedTech (Singapore), Ribbel International Ltd. (India), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (United States), Stryker Corporation (United States), Well Lead Medical Co., Ltd. (China), Medtronic (Ireland), Boston Scientific Corporation (United States) and Cook Medical (United States)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Urology market throughout the predicted period.

Advanced MedTech (Singapore), Ribbel International Ltd. (India), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (United States), Stryker Corporation (United States), Well Lead Medical Co., Ltd. (China), Medtronic (Ireland), Boston Scientific Corporation (United States) and Cook Medical (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Teleflex Incorporated (United States), Cardinal Health (United States), Amsino International, Inc. (United States), Olympus Corporation (Japan) and Baxter International (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Urology market by Type and Region with country level break-up.

On the basis of geography, the market of Urology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In August 2023, Abbott collaborates with patient advocacy groups to launch awareness campaigns on men's health issues, including prostate cancer and erectile dysfunction.
In October 2023, Intuitive Surgical receives FDA approval for its Ion robotic system, designed for minimally invasive urological procedures with enhanced dexterity and visualization.


Influencing Trend:
Emerging Trend of Miniaturization and Development of Optical Technology and Robotics Constitute for Surgical Procedures and Significant Inclination Towards Telemedicine During and Post Pandemic for Treating Some Common Urological Conditions

Market Growth Drivers:
Increasing Urological Problems Including Urinary Incontinence and Prostate Cancer in Men Due to Smoking Habits and High Body Mass Index, Growing Popularity of Minimally Invasive Treatments to Reduce the Invasiveness of Interventions and Continuous Growth of Urology Procedures in the Ambulatory Surgical Centers and Outpatient Sites

Challenges:
Chances of Mechanical Failure and Accidental Burn Injuries in Robotic Surgeries As Well As Requirement of Longer Duration to Perform Robot-Assisted Surgery

Restraints:
High Cost Associated with Advanced and Innovative Urology Devices and Treatments, Lack of Awareness May Slow Down the Growth of the Market in Underdeveloped Countries and Rural Areas

Opportunities:
Increasing Number of People With Urinary Tract Infection in Asian Countries Especially in Developing Economies

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Urology Treatment Providers, Urology Drugs & Devices Manufacturers, Urology Drugs & Devices Suppliers and Distributors, Venture Capitalists and Private Equity Firms, Regulatory Bodies, Research Organizations, End-Users and Others

Report Objectives / Segmentation Covered

By Therapies
  • Medications
  • Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)}
  • Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others}

By End Users
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Dialysis Centers
  • Nephrological Centers

By Disease Type
  • Benign prostatic hyperplasia
  • Cancer
  • Urinary Tract Infection
  • Stone Diseases
  • Others

By Gender
  • Male
  • Female

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Urological Problems Including Urinary Incontinence and Prostate Cancer in Men Due to Smoking Habits and High Body Mass Index
      • 3.2.2. Growing Popularity of Minimally Invasive Treatments to Reduce the Invasiveness of Interventions
      • 3.2.3. Continuous Growth of Urology Procedures in the Ambulatory Surgical Centers and Outpatient Sites
    • 3.3. Market Challenges
      • 3.3.1. Chances of Mechanical Failure and Accidental Burn Injuries in Robotic Surgeries As Well As Requirement of Longer Duration to Perform Robot-Assisted Surgery
    • 3.4. Market Trends
      • 3.4.1. Emerging Trend of Miniaturization and Development of Optical Technology and Robotics Constitute for Surgical Procedures
      • 3.4.2. Significant Inclination Towards Telemedicine During and Post Pandemic for Treating Some Common Urological Conditions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Urology, by Therapies, End Users, Disease Type, Gender and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Urology (Value)
      • 5.2.1. Global Urology by: Therapies (Value)
        • 5.2.1.1. Medications
        • 5.2.1.2. Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)}
        • 5.2.1.3. Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others}
      • 5.2.2. Global Urology by: End Users (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Ambulatory Surgical Centers
        • 5.2.2.3. Dialysis Centers
        • 5.2.2.4. Nephrological Centers
      • 5.2.3. Global Urology by: Disease Type (Value)
        • 5.2.3.1. Benign prostatic hyperplasia
        • 5.2.3.2. Cancer
        • 5.2.3.3. Urinary Tract Infection
        • 5.2.3.4. Stone Diseases
        • 5.2.3.5. Others
      • 5.2.4. Global Urology by: Gender (Value)
        • 5.2.4.1. Male
        • 5.2.4.2. Female
      • 5.2.5. Global Urology Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Urology (Price)
  • 6. Urology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Advanced MedTech (Singapore)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ribbel International Ltd. (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Stryker Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Well Lead Medical Co., Ltd. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medtronic (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Boston Scientific Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cook Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Urology Sale, by Therapies, End Users, Disease Type, Gender and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Urology (Value)
      • 7.2.1. Global Urology by: Therapies (Value)
        • 7.2.1.1. Medications
        • 7.2.1.2. Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)}
        • 7.2.1.3. Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others}
      • 7.2.2. Global Urology by: End Users (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Ambulatory Surgical Centers
        • 7.2.2.3. Dialysis Centers
        • 7.2.2.4. Nephrological Centers
      • 7.2.3. Global Urology by: Disease Type (Value)
        • 7.2.3.1. Benign prostatic hyperplasia
        • 7.2.3.2. Cancer
        • 7.2.3.3. Urinary Tract Infection
        • 7.2.3.4. Stone Diseases
        • 7.2.3.5. Others
      • 7.2.4. Global Urology by: Gender (Value)
        • 7.2.4.1. Male
        • 7.2.4.2. Female
      • 7.2.5. Global Urology Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Urology (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Urology: by Therapies(USD Million)
  • Table 2. Urology Medications , by Region USD Million (2018-2023)
  • Table 3. Urology Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)} , by Region USD Million (2018-2023)
  • Table 4. Urology Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others} , by Region USD Million (2018-2023)
  • Table 5. Urology: by End Users(USD Million)
  • Table 6. Urology Hospitals & Clinics , by Region USD Million (2018-2023)
  • Table 7. Urology Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 8. Urology Dialysis Centers , by Region USD Million (2018-2023)
  • Table 9. Urology Nephrological Centers , by Region USD Million (2018-2023)
  • Table 10. Urology: by Disease Type(USD Million)
  • Table 11. Urology Benign prostatic hyperplasia , by Region USD Million (2018-2023)
  • Table 12. Urology Cancer , by Region USD Million (2018-2023)
  • Table 13. Urology Urinary Tract Infection , by Region USD Million (2018-2023)
  • Table 14. Urology Stone Diseases , by Region USD Million (2018-2023)
  • Table 15. Urology Others , by Region USD Million (2018-2023)
  • Table 16. Urology: by Gender(USD Million)
  • Table 17. Urology Male , by Region USD Million (2018-2023)
  • Table 18. Urology Female , by Region USD Million (2018-2023)
  • Table 19. South America Urology, by Country USD Million (2018-2023)
  • Table 20. South America Urology, by Therapies USD Million (2018-2023)
  • Table 21. South America Urology, by End Users USD Million (2018-2023)
  • Table 22. South America Urology, by Disease Type USD Million (2018-2023)
  • Table 23. South America Urology, by Gender USD Million (2018-2023)
  • Table 24. Brazil Urology, by Therapies USD Million (2018-2023)
  • Table 25. Brazil Urology, by End Users USD Million (2018-2023)
  • Table 26. Brazil Urology, by Disease Type USD Million (2018-2023)
  • Table 27. Brazil Urology, by Gender USD Million (2018-2023)
  • Table 28. Argentina Urology, by Therapies USD Million (2018-2023)
  • Table 29. Argentina Urology, by End Users USD Million (2018-2023)
  • Table 30. Argentina Urology, by Disease Type USD Million (2018-2023)
  • Table 31. Argentina Urology, by Gender USD Million (2018-2023)
  • Table 32. Rest of South America Urology, by Therapies USD Million (2018-2023)
  • Table 33. Rest of South America Urology, by End Users USD Million (2018-2023)
  • Table 34. Rest of South America Urology, by Disease Type USD Million (2018-2023)
  • Table 35. Rest of South America Urology, by Gender USD Million (2018-2023)
  • Table 36. Asia Pacific Urology, by Country USD Million (2018-2023)
  • Table 37. Asia Pacific Urology, by Therapies USD Million (2018-2023)
  • Table 38. Asia Pacific Urology, by End Users USD Million (2018-2023)
  • Table 39. Asia Pacific Urology, by Disease Type USD Million (2018-2023)
  • Table 40. Asia Pacific Urology, by Gender USD Million (2018-2023)
  • Table 41. China Urology, by Therapies USD Million (2018-2023)
  • Table 42. China Urology, by End Users USD Million (2018-2023)
  • Table 43. China Urology, by Disease Type USD Million (2018-2023)
  • Table 44. China Urology, by Gender USD Million (2018-2023)
  • Table 45. Japan Urology, by Therapies USD Million (2018-2023)
  • Table 46. Japan Urology, by End Users USD Million (2018-2023)
  • Table 47. Japan Urology, by Disease Type USD Million (2018-2023)
  • Table 48. Japan Urology, by Gender USD Million (2018-2023)
  • Table 49. India Urology, by Therapies USD Million (2018-2023)
  • Table 50. India Urology, by End Users USD Million (2018-2023)
  • Table 51. India Urology, by Disease Type USD Million (2018-2023)
  • Table 52. India Urology, by Gender USD Million (2018-2023)
  • Table 53. South Korea Urology, by Therapies USD Million (2018-2023)
  • Table 54. South Korea Urology, by End Users USD Million (2018-2023)
  • Table 55. South Korea Urology, by Disease Type USD Million (2018-2023)
  • Table 56. South Korea Urology, by Gender USD Million (2018-2023)
  • Table 57. Australia Urology, by Therapies USD Million (2018-2023)
  • Table 58. Australia Urology, by End Users USD Million (2018-2023)
  • Table 59. Australia Urology, by Disease Type USD Million (2018-2023)
  • Table 60. Australia Urology, by Gender USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific Urology, by Therapies USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Urology, by End Users USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Urology, by Disease Type USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Urology, by Gender USD Million (2018-2023)
  • Table 65. Europe Urology, by Country USD Million (2018-2023)
  • Table 66. Europe Urology, by Therapies USD Million (2018-2023)
  • Table 67. Europe Urology, by End Users USD Million (2018-2023)
  • Table 68. Europe Urology, by Disease Type USD Million (2018-2023)
  • Table 69. Europe Urology, by Gender USD Million (2018-2023)
  • Table 70. Germany Urology, by Therapies USD Million (2018-2023)
  • Table 71. Germany Urology, by End Users USD Million (2018-2023)
  • Table 72. Germany Urology, by Disease Type USD Million (2018-2023)
  • Table 73. Germany Urology, by Gender USD Million (2018-2023)
  • Table 74. France Urology, by Therapies USD Million (2018-2023)
  • Table 75. France Urology, by End Users USD Million (2018-2023)
  • Table 76. France Urology, by Disease Type USD Million (2018-2023)
  • Table 77. France Urology, by Gender USD Million (2018-2023)
  • Table 78. Italy Urology, by Therapies USD Million (2018-2023)
  • Table 79. Italy Urology, by End Users USD Million (2018-2023)
  • Table 80. Italy Urology, by Disease Type USD Million (2018-2023)
  • Table 81. Italy Urology, by Gender USD Million (2018-2023)
  • Table 82. United Kingdom Urology, by Therapies USD Million (2018-2023)
  • Table 83. United Kingdom Urology, by End Users USD Million (2018-2023)
  • Table 84. United Kingdom Urology, by Disease Type USD Million (2018-2023)
  • Table 85. United Kingdom Urology, by Gender USD Million (2018-2023)
  • Table 86. Netherlands Urology, by Therapies USD Million (2018-2023)
  • Table 87. Netherlands Urology, by End Users USD Million (2018-2023)
  • Table 88. Netherlands Urology, by Disease Type USD Million (2018-2023)
  • Table 89. Netherlands Urology, by Gender USD Million (2018-2023)
  • Table 90. Rest of Europe Urology, by Therapies USD Million (2018-2023)
  • Table 91. Rest of Europe Urology, by End Users USD Million (2018-2023)
  • Table 92. Rest of Europe Urology, by Disease Type USD Million (2018-2023)
  • Table 93. Rest of Europe Urology, by Gender USD Million (2018-2023)
  • Table 94. MEA Urology, by Country USD Million (2018-2023)
  • Table 95. MEA Urology, by Therapies USD Million (2018-2023)
  • Table 96. MEA Urology, by End Users USD Million (2018-2023)
  • Table 97. MEA Urology, by Disease Type USD Million (2018-2023)
  • Table 98. MEA Urology, by Gender USD Million (2018-2023)
  • Table 99. Middle East Urology, by Therapies USD Million (2018-2023)
  • Table 100. Middle East Urology, by End Users USD Million (2018-2023)
  • Table 101. Middle East Urology, by Disease Type USD Million (2018-2023)
  • Table 102. Middle East Urology, by Gender USD Million (2018-2023)
  • Table 103. Africa Urology, by Therapies USD Million (2018-2023)
  • Table 104. Africa Urology, by End Users USD Million (2018-2023)
  • Table 105. Africa Urology, by Disease Type USD Million (2018-2023)
  • Table 106. Africa Urology, by Gender USD Million (2018-2023)
  • Table 107. North America Urology, by Country USD Million (2018-2023)
  • Table 108. North America Urology, by Therapies USD Million (2018-2023)
  • Table 109. North America Urology, by End Users USD Million (2018-2023)
  • Table 110. North America Urology, by Disease Type USD Million (2018-2023)
  • Table 111. North America Urology, by Gender USD Million (2018-2023)
  • Table 112. United States Urology, by Therapies USD Million (2018-2023)
  • Table 113. United States Urology, by End Users USD Million (2018-2023)
  • Table 114. United States Urology, by Disease Type USD Million (2018-2023)
  • Table 115. United States Urology, by Gender USD Million (2018-2023)
  • Table 116. Canada Urology, by Therapies USD Million (2018-2023)
  • Table 117. Canada Urology, by End Users USD Million (2018-2023)
  • Table 118. Canada Urology, by Disease Type USD Million (2018-2023)
  • Table 119. Canada Urology, by Gender USD Million (2018-2023)
  • Table 120. Mexico Urology, by Therapies USD Million (2018-2023)
  • Table 121. Mexico Urology, by End Users USD Million (2018-2023)
  • Table 122. Mexico Urology, by Disease Type USD Million (2018-2023)
  • Table 123. Mexico Urology, by Gender USD Million (2018-2023)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Urology: by Therapies(USD Million)
  • Table 134. Urology Medications , by Region USD Million (2025-2030)
  • Table 135. Urology Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)} , by Region USD Million (2025-2030)
  • Table 136. Urology Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others} , by Region USD Million (2025-2030)
  • Table 137. Urology: by End Users(USD Million)
  • Table 138. Urology Hospitals & Clinics , by Region USD Million (2025-2030)
  • Table 139. Urology Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 140. Urology Dialysis Centers , by Region USD Million (2025-2030)
  • Table 141. Urology Nephrological Centers , by Region USD Million (2025-2030)
  • Table 142. Urology: by Disease Type(USD Million)
  • Table 143. Urology Benign prostatic hyperplasia , by Region USD Million (2025-2030)
  • Table 144. Urology Cancer , by Region USD Million (2025-2030)
  • Table 145. Urology Urinary Tract Infection , by Region USD Million (2025-2030)
  • Table 146. Urology Stone Diseases , by Region USD Million (2025-2030)
  • Table 147. Urology Others , by Region USD Million (2025-2030)
  • Table 148. Urology: by Gender(USD Million)
  • Table 149. Urology Male , by Region USD Million (2025-2030)
  • Table 150. Urology Female , by Region USD Million (2025-2030)
  • Table 151. South America Urology, by Country USD Million (2025-2030)
  • Table 152. South America Urology, by Therapies USD Million (2025-2030)
  • Table 153. South America Urology, by End Users USD Million (2025-2030)
  • Table 154. South America Urology, by Disease Type USD Million (2025-2030)
  • Table 155. South America Urology, by Gender USD Million (2025-2030)
  • Table 156. Brazil Urology, by Therapies USD Million (2025-2030)
  • Table 157. Brazil Urology, by End Users USD Million (2025-2030)
  • Table 158. Brazil Urology, by Disease Type USD Million (2025-2030)
  • Table 159. Brazil Urology, by Gender USD Million (2025-2030)
  • Table 160. Argentina Urology, by Therapies USD Million (2025-2030)
  • Table 161. Argentina Urology, by End Users USD Million (2025-2030)
  • Table 162. Argentina Urology, by Disease Type USD Million (2025-2030)
  • Table 163. Argentina Urology, by Gender USD Million (2025-2030)
  • Table 164. Rest of South America Urology, by Therapies USD Million (2025-2030)
  • Table 165. Rest of South America Urology, by End Users USD Million (2025-2030)
  • Table 166. Rest of South America Urology, by Disease Type USD Million (2025-2030)
  • Table 167. Rest of South America Urology, by Gender USD Million (2025-2030)
  • Table 168. Asia Pacific Urology, by Country USD Million (2025-2030)
  • Table 169. Asia Pacific Urology, by Therapies USD Million (2025-2030)
  • Table 170. Asia Pacific Urology, by End Users USD Million (2025-2030)
  • Table 171. Asia Pacific Urology, by Disease Type USD Million (2025-2030)
  • Table 172. Asia Pacific Urology, by Gender USD Million (2025-2030)
  • Table 173. China Urology, by Therapies USD Million (2025-2030)
  • Table 174. China Urology, by End Users USD Million (2025-2030)
  • Table 175. China Urology, by Disease Type USD Million (2025-2030)
  • Table 176. China Urology, by Gender USD Million (2025-2030)
  • Table 177. Japan Urology, by Therapies USD Million (2025-2030)
  • Table 178. Japan Urology, by End Users USD Million (2025-2030)
  • Table 179. Japan Urology, by Disease Type USD Million (2025-2030)
  • Table 180. Japan Urology, by Gender USD Million (2025-2030)
  • Table 181. India Urology, by Therapies USD Million (2025-2030)
  • Table 182. India Urology, by End Users USD Million (2025-2030)
  • Table 183. India Urology, by Disease Type USD Million (2025-2030)
  • Table 184. India Urology, by Gender USD Million (2025-2030)
  • Table 185. South Korea Urology, by Therapies USD Million (2025-2030)
  • Table 186. South Korea Urology, by End Users USD Million (2025-2030)
  • Table 187. South Korea Urology, by Disease Type USD Million (2025-2030)
  • Table 188. South Korea Urology, by Gender USD Million (2025-2030)
  • Table 189. Australia Urology, by Therapies USD Million (2025-2030)
  • Table 190. Australia Urology, by End Users USD Million (2025-2030)
  • Table 191. Australia Urology, by Disease Type USD Million (2025-2030)
  • Table 192. Australia Urology, by Gender USD Million (2025-2030)
  • Table 193. Rest of Asia-Pacific Urology, by Therapies USD Million (2025-2030)
  • Table 194. Rest of Asia-Pacific Urology, by End Users USD Million (2025-2030)
  • Table 195. Rest of Asia-Pacific Urology, by Disease Type USD Million (2025-2030)
  • Table 196. Rest of Asia-Pacific Urology, by Gender USD Million (2025-2030)
  • Table 197. Europe Urology, by Country USD Million (2025-2030)
  • Table 198. Europe Urology, by Therapies USD Million (2025-2030)
  • Table 199. Europe Urology, by End Users USD Million (2025-2030)
  • Table 200. Europe Urology, by Disease Type USD Million (2025-2030)
  • Table 201. Europe Urology, by Gender USD Million (2025-2030)
  • Table 202. Germany Urology, by Therapies USD Million (2025-2030)
  • Table 203. Germany Urology, by End Users USD Million (2025-2030)
  • Table 204. Germany Urology, by Disease Type USD Million (2025-2030)
  • Table 205. Germany Urology, by Gender USD Million (2025-2030)
  • Table 206. France Urology, by Therapies USD Million (2025-2030)
  • Table 207. France Urology, by End Users USD Million (2025-2030)
  • Table 208. France Urology, by Disease Type USD Million (2025-2030)
  • Table 209. France Urology, by Gender USD Million (2025-2030)
  • Table 210. Italy Urology, by Therapies USD Million (2025-2030)
  • Table 211. Italy Urology, by End Users USD Million (2025-2030)
  • Table 212. Italy Urology, by Disease Type USD Million (2025-2030)
  • Table 213. Italy Urology, by Gender USD Million (2025-2030)
  • Table 214. United Kingdom Urology, by Therapies USD Million (2025-2030)
  • Table 215. United Kingdom Urology, by End Users USD Million (2025-2030)
  • Table 216. United Kingdom Urology, by Disease Type USD Million (2025-2030)
  • Table 217. United Kingdom Urology, by Gender USD Million (2025-2030)
  • Table 218. Netherlands Urology, by Therapies USD Million (2025-2030)
  • Table 219. Netherlands Urology, by End Users USD Million (2025-2030)
  • Table 220. Netherlands Urology, by Disease Type USD Million (2025-2030)
  • Table 221. Netherlands Urology, by Gender USD Million (2025-2030)
  • Table 222. Rest of Europe Urology, by Therapies USD Million (2025-2030)
  • Table 223. Rest of Europe Urology, by End Users USD Million (2025-2030)
  • Table 224. Rest of Europe Urology, by Disease Type USD Million (2025-2030)
  • Table 225. Rest of Europe Urology, by Gender USD Million (2025-2030)
  • Table 226. MEA Urology, by Country USD Million (2025-2030)
  • Table 227. MEA Urology, by Therapies USD Million (2025-2030)
  • Table 228. MEA Urology, by End Users USD Million (2025-2030)
  • Table 229. MEA Urology, by Disease Type USD Million (2025-2030)
  • Table 230. MEA Urology, by Gender USD Million (2025-2030)
  • Table 231. Middle East Urology, by Therapies USD Million (2025-2030)
  • Table 232. Middle East Urology, by End Users USD Million (2025-2030)
  • Table 233. Middle East Urology, by Disease Type USD Million (2025-2030)
  • Table 234. Middle East Urology, by Gender USD Million (2025-2030)
  • Table 235. Africa Urology, by Therapies USD Million (2025-2030)
  • Table 236. Africa Urology, by End Users USD Million (2025-2030)
  • Table 237. Africa Urology, by Disease Type USD Million (2025-2030)
  • Table 238. Africa Urology, by Gender USD Million (2025-2030)
  • Table 239. North America Urology, by Country USD Million (2025-2030)
  • Table 240. North America Urology, by Therapies USD Million (2025-2030)
  • Table 241. North America Urology, by End Users USD Million (2025-2030)
  • Table 242. North America Urology, by Disease Type USD Million (2025-2030)
  • Table 243. North America Urology, by Gender USD Million (2025-2030)
  • Table 244. United States Urology, by Therapies USD Million (2025-2030)
  • Table 245. United States Urology, by End Users USD Million (2025-2030)
  • Table 246. United States Urology, by Disease Type USD Million (2025-2030)
  • Table 247. United States Urology, by Gender USD Million (2025-2030)
  • Table 248. Canada Urology, by Therapies USD Million (2025-2030)
  • Table 249. Canada Urology, by End Users USD Million (2025-2030)
  • Table 250. Canada Urology, by Disease Type USD Million (2025-2030)
  • Table 251. Canada Urology, by Gender USD Million (2025-2030)
  • Table 252. Mexico Urology, by Therapies USD Million (2025-2030)
  • Table 253. Mexico Urology, by End Users USD Million (2025-2030)
  • Table 254. Mexico Urology, by Disease Type USD Million (2025-2030)
  • Table 255. Mexico Urology, by Gender USD Million (2025-2030)
  • Table 256. Research Programs/Design for This Report
  • Table 257. Key Data Information from Secondary Sources
  • Table 258. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Urology: by Therapies USD Million (2018-2023)
  • Figure 5. Global Urology: by End Users USD Million (2018-2023)
  • Figure 6. Global Urology: by Disease Type USD Million (2018-2023)
  • Figure 7. Global Urology: by Gender USD Million (2018-2023)
  • Figure 8. South America Urology Share (%), by Country
  • Figure 9. Asia Pacific Urology Share (%), by Country
  • Figure 10. Europe Urology Share (%), by Country
  • Figure 11. MEA Urology Share (%), by Country
  • Figure 12. North America Urology Share (%), by Country
  • Figure 13. Global Urology share by Players 2023 (%)
  • Figure 14. Global Urology share by Players (Top 3) 2023(%)
  • Figure 15. Global Urology share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Advanced MedTech (Singapore) Revenue, Net Income and Gross profit
  • Figure 18. Advanced MedTech (Singapore) Revenue: by Geography 2023
  • Figure 19. Ribbel International Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 20. Ribbel International Ltd. (India) Revenue: by Geography 2023
  • Figure 21. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 22. B. Braun Melsungen AG (Germany) Revenue: by Geography 2023
  • Figure 23. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton, Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 25. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Stryker Corporation (United States) Revenue: by Geography 2023
  • Figure 27. Well Lead Medical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 28. Well Lead Medical Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 29. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 31. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 33. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cook Medical (United States) Revenue: by Geography 2023
  • Figure 35. Global Urology: by Therapies USD Million (2025-2030)
  • Figure 36. Global Urology: by End Users USD Million (2025-2030)
  • Figure 37. Global Urology: by Disease Type USD Million (2025-2030)
  • Figure 38. Global Urology: by Gender USD Million (2025-2030)
  • Figure 39. South America Urology Share (%), by Country
  • Figure 40. Asia Pacific Urology Share (%), by Country
  • Figure 41. Europe Urology Share (%), by Country
  • Figure 42. MEA Urology Share (%), by Country
  • Figure 43. North America Urology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Advanced MedTech (Singapore)
  • Ribbel International Ltd. (India)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (United States)
  • Stryker Corporation (United States)
  • Well Lead Medical Co., Ltd. (China)
  • Medtronic (Ireland)
  • Boston Scientific Corporation (United States)
  • Cook Medical (United States)
Additional players considered in the study are as follows:
Teleflex Incorporated (United States) , Cardinal Health (United States) , Amsino International, Inc. (United States) , Olympus Corporation (Japan) , Baxter International (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 234 Pages 71 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Urology Market Quantitative research analysis
Global Urology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Urology Market are by end use application [].
The Urology Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Urological Problems Including Urinary Incontinence and Prostate Cancer in Men Due to Smoking Habits and High Body Mass Index
  • Growing Popularity of Minimally Invasive Treatments to Reduce the Invasiveness of Interventions
  • Continuous Growth of Urology Procedures in the Ambulatory Surgical Centers and Outpatient Sites

Know More About Global Urology Market Report?

Have a Query? Click Here

Other Related Reports

Antibody Discovery Comprehensive Study by Type (Monoclonal Antibodies, Polyclonal Antibodies, Other Antibodies), Application (Healthcare Industry), Nature (Humanized, Human, Chimeric, Murine), Method...
$ 3800
Shoulder Impingement Syndrome Comprehensive Study by Type (Structural, Functional), Shoulder Impingement Syndrome (Anterior Acromial Impingement, Posterosuperior Glenoid Rim Impingement, Subcoracoid ...
$ 4000
In-vivo Contract Research Organization Comprehensive Study by Services (Clinical Trials, Research Support), Therapeutic Areas (Autoimmune, Pain Management, Oncology, Nephrology, Diabetes, Cardiovascu...
$ 3800
Heart Transplant Comprehensive Study by Demographics (Gender, -Male, -Female, -Unisex, Age, -0-10 Years, -11-29 Years, -30-49 Years, -50-69 Years, Others), End Users (Hospitals, Cardiac Institute, Ot...
$ 3800
Systemic Psoriasis Therapeutic Comprehensive Study by Type (Plaque Psoriasis, Psoriatic Arthritis, Others), Route of Administration (Oral, Parenteral/Systemic, Topical), Distribution Channel (Direct,...
$ 3800
Systemic Lupus Erythematosus Treatment Comprehensive Study by Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Antimalarial Drugs, Corticosteroids, Immunosuppressants, Biologics, Others), End use...
$ 3800